CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Ajanta Pharma USA Inc recalls Fluphenazine Hydrochloride Tablets

Read the official FDA notice

Published
16 Sept 2026
Units affected
403,200 tablets
Agency
FDA
Country
United States

The hazard

Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.

Brand / company
Ajanta Pharma USA Inc
Codes / lots
Lot #: DJ23254, Exp. Date 11/30/2026; DJ10205, Exp. Date 04/30/2027.
Distribution
Nationwide within the U.S
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 16 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.